Metraipolis › archive › dc_a862accc5ecf
COVID-19 outcomes in individuals with severe alpha-1 antitrypsin deficiency in Sweden — Europe PMC PMID:41526539
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41526539
- DOI
- 10.1038/s41598-[numero omesso]-4
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T21:45:24.701Z
- SHA-256 of the archived text
fe958f22b1e55377b809911f3d3ca103d953cc03bdad6e811d520910c718d859- Stable URL of this page
https://metraipolis.com/documento/dc_a862accc5ecf
How to cite
COVID-19 outcomes in individuals with severe alpha-1 antitrypsin deficiency in Sweden — Europe PMC PMID:41526539 — Europe PMC (en), https://europepmc.org/article/MED/41526539 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a862accc5ecf (Metraipolis archive dc_a862accc5ecf, sha256 fe958f22b1e55377b809911f3d3ca103d953cc03bdad6e811d520910c718d859)
BibTeX
@misc{dca862accc5ecf,
title = {COVID-19 outcomes in individuals with severe alpha-1 antitrypsin deficiency in Sweden — Europe PMC PMID:41526539},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41526539},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a862accc5ecf; sha256 fe958f22b1e55377b809911f3d3ca103d953cc03bdad6e811d520910c718d859},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41526539. Agents can read the archived copy with the MCP tool read_document.